|Bid||1.3100 x 3100|
|Ask||0.0000 x 1800|
|Day's Range||1.4700 - 1.5800|
|52 Week Range||1.4700 - 4.2500|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2023 - Nov 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.75|
CONCORD, Calif., September 12, 2023--Cerus Corporation (Nasdaq: CERS) announced today that Kevin Green, Cerus’ chief financial officer, is scheduled to participate at the 2023 Cantor Global Healthcare Conference on Tuesday, September 26, at 10:30 a.m. EST.
Cerus (CERS) delivered earnings and revenue surprises of -40% and 4.77%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CONCORD, Calif., August 02, 2023--Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023.